About the Authors
- Alessandro Tozzi
-
Affiliations Clinica Neurologica, Università di Perugia, Ospedale S. Maria della Misericordia, Perugia, Italy, Fondazione Santa Lucia - IRCCS, Rome, Italy
- Antonio de Iure
-
Affiliations Clinica Neurologica, Università di Perugia, Ospedale S. Maria della Misericordia, Perugia, Italy, Fondazione Santa Lucia - IRCCS, Rome, Italy
- Valentina Marsili
-
Affiliation CEINGE - Biotecnologie Avanzate, Naples, Italy
- Rosaria Romano
-
Affiliation CEINGE - Biotecnologie Avanzate, Naples, Italy
- Michela Tantucci
-
Affiliations Clinica Neurologica, Università di Perugia, Ospedale S. Maria della Misericordia, Perugia, Italy, Fondazione Santa Lucia - IRCCS, Rome, Italy
- Massimiliano Di Filippo
-
Affiliation Clinica Neurologica, Università di Perugia, Ospedale S. Maria della Misericordia, Perugia, Italy
- Cinzia Costa
-
Affiliation Clinica Neurologica, Università di Perugia, Ospedale S. Maria della Misericordia, Perugia, Italy
- Francesco Napolitano
-
Affiliation CEINGE - Biotecnologie Avanzate, Naples, Italy
- Nicola Biagio Mercuri
-
Affiliation Fondazione Santa Lucia - IRCCS, Rome, Italy
- Franco Borsini
-
Affiliation Sigma - tau Industrie Riunite, Pomezia, Italy
- Carmen Giampà
-
Affiliation Fondazione Santa Lucia - IRCCS, Rome, Italy
- Francesca Romana Fusco
-
Affiliation Fondazione Santa Lucia - IRCCS, Rome, Italy
- Barbara Picconi
-
Affiliation Fondazione Santa Lucia - IRCCS, Rome, Italy
- Alessandro Usiello
-
Affiliations CEINGE - Biotecnologie Avanzate, Naples, Italy, Second University of Naples (SUN), Naples, Italy
- Paolo Calabresi
-
* E-mail: calabre@unipg.it
Affiliations Clinica Neurologica, Università di Perugia, Ospedale S. Maria della Misericordia, Perugia, Italy, Fondazione Santa Lucia - IRCCS, Rome, Italy
Competing Interests
Dr. Calabresi serves as an editorial board member of Lancet Neurology, the Journal of Neuroscience, Movement Disorders and Synapse; receives research support from Bayer Schering, Biogen, Boehringer Ingelheim, Eisai, Novartis, Lundbeck, Sanofi-Aventis, Sigma-Tau, and UCB Pharma; and from Ricerca Corrente IRCCS, Ricerca Finalizzata IRCCS [European Community Grants SYNSCAFF and REPLACES], the Italian Minister of Health and AIFA (Agenzia Italiana del Farmaco). Dr. Franco Borsini is employed by Sigma-tau Industrie Riunite, Pomezia, Italy. This does not alter the authors’ adherence to all the PLoS ONE policies on sharing data and materials. All other authors reported no biomedical financial interests or potential conflicts of interest.
Author Contributions
Conceived and designed the experiments: AT AU PC. Performed the experiments: AT AD VM RR CG. Analyzed the data: AT AD VM RR CG CC FRF. Wrote the paper: AT MD NBM FB BP MT FN AU PC.